Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study-Reference-Cited by-同舟云学术

Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study

Published:2020-01-21 Issue:1 Volume:15 Page:e0227557
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hamilton Robin D.,Clemens Andreas^ORCID,Minnella Angelo Maria^ORCID,Lai Timothy Y. Y.,Dai Hong,Sakamoto Taiji,Gemmy Cheung Chui Ming,Ngah Nor Fariza,Dunger-Baldauf Cornelia,Holz Frank G.,

Funder

Novartis Pharma AG

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. Long-term effect of intravitreal injection of anti-VEGF agent for visual acuity and chorioretinal atrophy progression in myopic choroidal neovascularization;A Oishi;Graefes Arch Clin Exp Ophthalmol,2013

2. IMI—Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies;DI Flitcroft;Invest Ophthalmol Vis Sci,2019

3. Choroidal neovascularization in pathological myopia;K Neelam;Prog Retin Eye Res,2012

4. Ocular risk factors for choroidal neovascularization in pathologic myopia;Y Ikuno;Invest Ophthalmol Vis Sci,2010

5. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review;TY Wong;Am J Ophthalmol,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. INVESTIGATING THE PHYSICOCHEMICAL, NON-CLINICAL, AND CLINICAL CRITERIA FOR ASSESSING COMPARABILITY IN RANIBIZUMAB BIOSIMILARS: A COMPREHENSIVE REVIEW;FARMACIA;2024

2. Differential diagnosis of myopic choroidal neovascularization (mCNV): insights from multimodal imaging and treatment implications;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-12-07

3. Recurrence risk of myopic choroidal neovascularisation: a systematic review of current study;BMJ Open Ophthalmology;2023-10

4. Ten-year outcomes of intravitreal injection of ranibizumab for the treatment of myopic choroidal neovascularization: a retrospective study;2023-09-01

5. RISK FACTORS OF VISION LOSS AND MULTIPLE RECURRENCES IN MYOPIC MACULAR NEOVASCULARIZATION;Retina;2023-02